compound 3 [PMID: 32636746]   Click here for help

GtoPdb Ligand ID: 11159

Synonyms: example 6 [WO2019101906]
Compound class: Synthetic organic
Comment: Compound 3 is a small molecule B2 receptor antagonist that was a precursor for the design and development of the first-in-class, Phase 1 clinical lead PHA-022121 (Pharvaris) [1]. PHA-022121 is being developed as an oral drug for treatment and prevention of acute hereditary angioedema (HAE) attacks.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 91.16
Molecular weight 533.14
XLogP 4.64
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC(OCC(=O)N[C@H](c1cc(F)cc(c1COc1cccc2c1nc(C)cc2c1ncnn1C)Cl)C)F
Isomeric SMILES FC(OCC(=O)N[C@H](c1cc(F)cc(c1COc1cccc2c1nc(C)cc2c1ncnn1C)Cl)C)F
InChI InChI=1S/C25H23ClF3N5O3/c1-13-7-18(24-30-12-31-34(24)3)16-5-4-6-21(23(16)32-13)36-10-19-17(8-15(27)9-20(19)26)14(2)33-22(35)11-37-25(28)29/h4-9,12,14,25H,10-11H2,1-3H3,(H,33,35)/t14-/m0/s1
InChI Key ZTCLCSCHTACERP-AWEZNQCLSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
B2 receptor Hs Antagonist Antagonist 9.3 pKi - 1
pKi 9.3 (Ki 5x10-10 M) [1]
Description: Ki values at the human B2 receptor derived from a [3H]BK binding competition assay.